Commentary|Videos|December 2, 2025

2025 Veeva R&D and Quality Summit: Effectively Utilizing Clinical Reference Data

Author(s)Henry Galio

Explore the challenges sponsors and CROs face in maintaining clinical reference data, uncover the hidden costs of traditional upkeep models, and see how integrated data solutions can streamline operations across the clinical ecosystem.

Sponsored by Veeva

In this video, Henry Galio, vice president of clinical strategy at Veeva, explains the challenges sponsors and CROs face in managing clinical reference data and how traditional upkeep models create hidden operational and cost burdens. He describes why many large biopharmas rely on internal teams for data maintenance, the limitations of that approach, and the value of shifting to an integrated reference data solution that can streamline processes across the clinical ecosystem. Galio also highlights the top benefits of adopting a unified data strategy, including improved efficiency, reduced duplication, and greater alignment across clinical operations.

Watch and learn more:

  • The core challenges sponsors and CROs encounter when managing clinical reference data
  • The true and often hidden costs of maintaining data at scale
  • The alternatives to internal reference data upkeep and their advantages
  • The top benefits of moving to an integrated, ecosystem-wide data solution

Related to this article

The Next Evolution of Patient-Centered Trials Starts with Design
Decentralized trial success depends less on how far activities move away from sites than on matching each activity’s delivery model to participant burden, site readiness, and data integrity, using patient intelligence to decide where flexibility helps and where site-based care remains essential.
© putilov_denis - © putilov_denis - stock.adobe.com
Sponsors rigorously vet CROs for oncology expertise but rarely apply the same scrutiny to the IRB reviewing their trials, even though increasingly complex protocols require reviewers with substantive therapeutic knowledge, not just a rostered oncologist.